Clinical Trial

EPOCH-Economics and Patient Outcomes in China in Haemophilia

Study acronym: EPOCH
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The overarching goal of the EPOCH project is to: * Support a broad and robust needs assessment in the haemophilia space in China * Measure the variability in the needs and care provision * Generate outcome data (health economic outcomes and supporting clinical and PRO data) to enable measuring the impact of different treatment modalities and different levels of treatment access PRIMARY OBJECTIVES * Determine the burden of haemophilia in China, and the determinants of its variability * Determine the costs of haemophilia care in China, and the determinants of its variability SECONDARY OBJECTIVES * Measure treatment patterns and their variability * Measure levels of access to care * Estimate the impact of haemophilia and its treatment of patients reported outcomes * Understand consistency of care by centres/geography/demographics
Trial Details
NCT Number NCT07454239
Lead Sponsor Institute of Hematology & Blood Diseases Hospital, China
Collaborators: EPOCH Study, Ltd.
Conditions Hemophilia
Enrollment 500 participants
Start Date 2024-11-14
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-06